InMode Ltd. (INMD)
InMode Ltd. (INMD) Stock Price, Analysis & Data
| Bid | 10.8 |
| Market Cap | 875.43M |
| Revenue (ttm) | 374.62M |
| Net Income (ttm) | 77.51M |
| Beta | 1.87 |
| EPS (ttm) | 1.21 |
| PE Ratio (ttm) | 12.59 |
| Forward PE | 10.82 |
| P/B (ttm) | 1.43 |
| P/S (ttm) | 2.34 |
| Earnings Date | Nov 4, 2026 |
| Ask | 19.37 |
| Volume | 341,391 |
| Avg. Volume (20D) | 754,303 |
| Open | 15.02 |
| Previous Close | 15.14 |
| Day's Range | 15.02 - 15.28 |
| 52-Week Range | 12.72 - 16.74 |
| Analyst | Hold |
| Price Target | 15 (-1.51%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About INMD
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablativ...
Financial Performance
In 2025, InMode's revenue was 370.5M, a decrease of -6.16% compared to the previous year's 394.82M. Earnings were 93.83M, a decrease of -48.24%.
Financial StatementsAnalyst Forecast
According to 3 analyst ratings, the average rating for INMD stock is "Hold". The 12-month stock price forecast is 15, which is downside of 1.51% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
